Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Biotechnology Industry Organization

Executive Summary

Charles Ludlam to VP-government affairs succeeding Lisa Raines, who left the association to join Genzyme as a VP. Ludlam was previously the Senate Small Business Committee's chief tax counsel and a long- time aide to committee Chairman Bumpers (D-Ark.). Bumpers is a sponsor of legislation that would reduce capital gains taxes on start-up companies, a bill endorsed by the biotechnology industry. The merger of the Industrial Biotechnology Association and Association of Biotechnology Companies to form BIO becomes official July 1.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS022769

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel